D-0658-2020 Class II Terminated

Recalled by Hikma Pharmaceuticals USA Inc. — Cherry Hill, NJ

Recall Details

Product Type
Drugs
Report Date
January 22, 2020
Initiation Date
December 17, 2019
Termination Date
June 9, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
25,817 shelf packs/25 vials per pack

Product Description

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

Reason for Recall

Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

Distribution Pattern

Nationwide within the United States

Code Information

038368, Exp. Mar 2020; 058314, Exp. May 2020; 078305, 078307, Exp. July 2020; 118362 Exp. Nov 2020